Madhya Pradesh Laboratories Still Waiting For Green Light For Covid-19 Genome Sequencing | Bhopal News
Genome sequencing has been extended to Madhya Pradesh in virology laboratories pending ICMR approval. However, regular collection of samples for genome monitoring is necessary. Currently, random samples from Covid-19 patients are sent to NCDC New Delhi for genome sequencing.
Sequencing activities have been undertaken in AIIMS Bhopal. They have a working laboratory and equipment for the same. Genome sequencing for an academic and pilot basis has been undertaken at AIIMS Bhopal.
Currently, across PD, for all positive samples reported in the state for each district, 5% are screened for genome sequencing. In exceptional cases, such as an epidemic in a cluster, larger sampling could be done. Ideally, every 20th Covid-19 sample that is determined to be positive should be sent to NCDC for genome sequencing. Since the pandemic took hold, it has posed an unprecedented public health challenge. In order to fully understand the spread and evolution of the SARS CoV-2 virus, its mutations and resulting variants, the need for in-depth sequencing and analysis of genomic data is required. INSACOG was created to extend whole genome sequencing of the SARS-CoV-2 virus across India to help us understand how the virus spreads and evolves.